Table 1.
Demographic and clinical characteristics of patients with primary HNC by race/ethnicity.
| Characteristic N (%) | Overall N = 76,095 | NH-Black 8,595 (11.3) | Hispanic 5,136 (6.8) | NH-Asian/PI 5,087 (6.7) | NH-White 57,277 (75.3) |
|---|---|---|---|---|---|
| Age groups, year | |||||
| 20–49 years | 12,281 (16.1) | 1,566 (18.2) | 1,179 (23.0) | 1,471 (28.9) | 8,065 (14.1) |
| 50–64 years | 35,814 (47.1) | 4,531 (52.7) | 2,234 (43.5) | 1,959 (38.5) | 27,090 (47.3) |
| 65–79 years | 22,494 (29.6) | 2,166 (25.2) | 1,404 (27.3) | 1,294 (25.4) | 17,630 (30.8) |
| 80+ years | 5,506 (7.2) | 332 (3.9) | 319 (6.2) | 363 (7.1) | 4,492 (7.8) |
| Sex | |||||
| Female | 20,280 (26.6) | 2,429 (28.3) | 1,475 (28.7) | 1,663 (32.7) | 14,713 (25.7) |
| Male | 55,815 (73.4) | 6,166 (71.7) | 3,661 (71.3) | 3,424 (67.3) | 42,564 (74.3) |
| Marital status | |||||
| Married or Partnered | 41,337 (54.3) | 2,900 (33.7) | 2,614 (50.9) | 3,456 (67.9) | 32,367 (56.5) |
| Other | 34,758 (45.7) | 5,695 (66.3) | 2,522 (49.1) | 1,631 (32.1) | 24,910 (43.5) |
| SES index (quintiles) | |||||
| Group 1 (lowest) | 13,558 (17.8) | 4,270 (49.7) | 1,199 (23.4) | 362 (7.6) | 7,727 (13.5) |
| Group 2 (low-middle) | 13,128 (17.3) | 1,751 (20.4) | 1,102 (21.5) | 527 (10.4) | 9,748 (17.0) |
| Group 3 (middle) | 13,621 (17.9) | 1,083 (12.6) | 959 (18.7) | 781 (15.4) | 10,798 (18.9) |
| Group 4 (high-middle) | 16,129 (21.2) | 919 (10.7) | 946 (18.4) | 1,328 (26.1) | 12,936 (22.6) |
| Group 5 (highest) | 19,659 (25.8) | 572 (6.7) | 930 (18.1) | 2,089 (41.1) | 16,068 (28.1) |
| Primary site | |||||
| Oral cavity | 25,782 (33.8) | 2,181 (25.3) | 1,880 (36.6) | 2,024 (39.8) | 19,697 (34.4) |
| Pharyngeal | 29,901 (39.3) | 3,083 (35.9) | 1,764 (34.3) | 2,259 (44.4) | 22,795 (39.8) |
| Sinonasal | 3,173 (4.2) | 353 (4.1) | 307 (6.0) | 250 (4.9) | 2,263 (4.0) |
| Larynx | 17,239 (22.7) | 2,978 (34.7) | 1,185 (23.1) | 554 (10.9) | 12,522 (21.8) |
| Stage | |||||
| Localized | 29,147 (38.3) | 2,861 (33.3) | 1,972 (38.4) | 1,804 (35.5) | 22,510 (39.3) |
| Regional | 32,648 (42.9) | 3,545 (41.2) | 2,065 (40.2) | 2,031 (39.9) | 25,007 (43.7) |
| Distant | 11,733 (15.4) | 1,938 (22.6) | 876 (17.1) | 1,066 (21.0) | 7,853 (13.7) |
| Unknown | 2,567 (3.4) | 251 (2.9) | 223 (4.8) | 186 (3.7) | 1,907 (3.3) |
| Histology type | |||||
| Squamous | 64,884 (85.3) | 7,203 (83.8) | 4,065 (79.2) | 3,481 (68.4) | 50,135 (87.6) |
| Adenoma/Adeno | 2,823 (3.7) | 348 (4.1) | 277 (5.4) | 285 (5.6) | 1,913 (3.3) |
| Other type | 8,388 (11.0) | 1,044 (12.1) | 794 (15.4) | 1,321 (26.0) | 5,229 (9.1) |
| Surgery | |||||
| Yes | 40,970 (53.8) | 3,741 (43.5) | 2,961 (57.7) | 2,665 (52.4) | 31,603 (55.2) |
| No | 35,125 (46.2) | 4,854 (56.5) | 2,175 (42.4) | 2,422 (47.6) | 25,674 (44.8) |
| Radiotherapy | |||||
| Yes | 53,506 (70.3) | 6,667 (77.6) | 3,478 (67.7) | 3,542 (69.6) | 39,819 (69.5) |
| No | 22,589 (29.7) | 1,928 (22.4) | 1,658 (32.3) | 1,545 (30.4) | 17,458 (30.5) |
| Chemotherapy | |||||
| Yes | 33,424 (43.9) | 4,285 (49.9) | 2,160 (42.1) | 2,385 (46.9) | 24,594 (42.9) |
| No/unknown | 42,671 (56.1) | 4,310 (50.1) | 2,976 (57.9) | 2,702 (53.1) | 32,683 (57.1) |
| Year of diagnosis | |||||
| 2006–2010 | 23,234 (30.5) | 2,705 (31.4) | 1,537 (29.9) | 1,520 (29.9) | 17,472 (30.5) |
| 2011–2013 | 25,796 (33.9) | 2,886 (33.6) | 1,756 (34.2) | 1,702 (33.5) | 19,452 (34.0) |
| 2014–2017 | 27,065 (35.6) | 3,004 (35.0) | 1,843 (35.9) | 1,865 (36.7) | 20,353 (35.5) |
| Years of follow-up | |||||
| Median (IQR) | 4.3 (2.5–7.5) | 3.6 (1.8–6.8) | 4.2 (2.0–7.3) | 4.3 (2.2–7.6) | 4.4 (2.3–7.5) |
Oral cavity, oral cavity, and salivary gland tumors; pharyngeal, oropharyngeal, nasopharynx, and hypopharynx; sinonasal, nasal cavity, and paranasal sinus; marital status other; never married/divorced/separated/widowed/unknown.
Abbreviation: PI, Pacific Islander.